000566 Stock Overview
Manufactures and sells pharmaceutical products and medical devices in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Hainan Haiyao Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.82 |
| 52 Week High | CN¥7.11 |
| 52 Week Low | CN¥2.83 |
| Beta | 0.45 |
| 1 Month Change | -5.12% |
| 3 Month Change | 25.85% |
| 1 Year Change | 7.83% |
| 3 Year Change | -4.18% |
| 5 Year Change | -19.40% |
| Change since IPO | 508.84% |
Recent News & Updates
What Hainan Haiyao Co., Ltd.'s (SZSE:000566) 31% Share Price Gain Is Not Telling You
Oct 25
Hainan Haiyao (SZSE:000566) Is Carrying A Fair Bit Of Debt
Oct 06Recent updates
What Hainan Haiyao Co., Ltd.'s (SZSE:000566) 31% Share Price Gain Is Not Telling You
Oct 25Hainan Haiyao (SZSE:000566) Is Carrying A Fair Bit Of Debt
Oct 06Revenues Not Telling The Story For Hainan Haiyao Co., Ltd. (SZSE:000566)
Sep 09Hainan Haiyao Co., Ltd.'s (SZSE:000566) Shares May Have Run Too Fast Too Soon
Jun 07Investor Optimism Abounds Hainan Haiyao Co., Ltd. (SZSE:000566) But Growth Is Lacking
Feb 26Shareholder Returns
| 000566 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -10.4% | -1.7% | -1.0% |
| 1Y | 7.8% | -4.3% | 10.8% |
Return vs Industry: 000566 exceeded the CN Pharmaceuticals industry which returned -3% over the past year.
Return vs Market: 000566 underperformed the CN Market which returned 12.3% over the past year.
Price Volatility
| 000566 volatility | |
|---|---|
| 000566 Average Weekly Movement | 11.6% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 000566's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 000566's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1965 | 2,108 | Junhong Wang | www.haiyao.com.cn |
Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company develops intermediates, APIs, innovative chemical drugs, modern Chinese medicines, biological drugs, cellular immunity products, and high-end medical devices. It offers its products in various forms, such as pills, tablet granules, tincture fluid extracts, powders, syrups, soft capsule raw materials, powder injections, and health foods in various antibiotic series, gastrointestinal medication series, anti-tumor medicine series, cochlear implant series, etc.; and vitamin C for injection scurvy, idiopathic methemoglobinemia, etc. The company also provides internet medical treatment and medical services.
Hainan Haiyao Co., Ltd. Fundamentals Summary
| 000566 fundamental statistics | |
|---|---|
| Market cap | CN¥6.25b |
| Earnings (TTM) | -CN¥377.13m |
| Revenue (TTM) | CN¥1.03b |
6.1x
P/S Ratio-16.6x
P/E RatioIs 000566 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000566 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.03b |
| Cost of Revenue | CN¥638.68m |
| Gross Profit | CN¥391.97m |
| Other Expenses | CN¥769.11m |
| Earnings | -CN¥377.13m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.29 |
| Gross Margin | 38.03% |
| Net Profit Margin | -36.59% |
| Debt/Equity Ratio | 226.0% |
How did 000566 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 07:34 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hainan Haiyao Co., Ltd. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhouyu Deng | Guosen Securities Co., Ltd. |
| Wenxin Yu | Haitong Securities Co., Ltd. |
| Ye Hui Yang | Huatai Research |